One of the more difficult decisions for patients with poorly controlled type 2 diabetes, as well as for their clinicians, is when to add or switch to daily insulin therapy. Initiation of longer-acting insulins, such as glargine or degludec, administered at bedtime, has gained widespread use and is effective in…
